Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Verrica Pharmaceuticals stock has a target of 17, which predicts a 111.18% increase from the current stock price of 8.05.

Price Target: $17 (+111.18%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$17	$17	$17	$17
Change	+111.18%	+111.18%	+111.18%	+111.18%

Analyst Ratings

The average analyst rating for Verrica Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	4	4	4	4	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kemp Dolliver Brookline Capital	Brookline Capital	Hold → Strong Buy Upgrades $17	Hold → Strong Buy	Upgrades	$17	+111.18%	Dec 18, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 14, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 9, 2025
Oren Livnat HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 8, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

35.80M

Increased by 373.20%

from 7.57M

Revenue Next Year

27.06M

Decreased by -24.41%

from 35.80M

EPS This Year

-1.37

from -14.78

EPS Next Year

-1.21

from -1.37

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	12.00M	9.03M	5.12M	7.57M	35.80M	27.06M
Revenue Growth	-	-	-24.73%	-43.27%	47.66%	373.20%	-24.41%
EPS	-17.08	-13.00	-7.17	-14.78	-14.78	-1.37	-1.21
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	37.6M	31.8M
Avg	35.8M	27.1M
Low	33.8M	19.6M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	396.8%	-11.1%
Avg	373.2%	-24.4%
Low	346.9%	-45.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-0.60	-1.04
Avg	-1.37	-1.21
Low	-2.07	-1.50

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.